Skip to content

Difference in the Metabolic Characteristics of COPD Patients and Healthy Adults

Difference in the Metabolic Characteristics of COPD Patients and Healthy Adults

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04046666
Enrollment
120
Registered
2019-08-06
Start date
2020-01-03
Completion date
2021-12-31
Last updated
2020-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

meridians, acupuncture, chronic obstructive pulmonary disease, meridian phenomenon, near infrared spectroscopy

Brief summary

Although some important progresses were made in the field of the meridian research, no breakthroughs have been achieved. Besides,there are some problems in meridian researches. Particularly, previous research of meridian phenomenon involved lots of subjective elements and outcomes.Researches that use modern scientific techniques to investigate the biological characteristics of meridians are urgently needed. Therefore, this study is designed to assess the metabolic characteristics of the Heart and Lung meridians by using functional near infrared spectroscopy. Thus, the biological characteristics of meridians could be presented objectively in a scientific methodology.

Detailed description

The Lung and Heart meridians are chosen as two specific studied meridians. Participants of chronic obstructive pulmonary disease (COPD) and healthy volunteers will be enrolled. 120 participants will be included and divided into the healthy control group, chronic obstructive pulmonary disease (COPD) group and healthy intervention group. Functional near infrared spectroscopy will be used to assess the metabolic characteristics of the Heart and Lung meridians. The specificity for the meridian-visceral association will be investigated by comparing the metabolic difference between the Heart and Lung meridians in the healthy control group and COPD group. Besides, participants in the healthy intervention group will receive two sessions of moxibustion in the Heart meridian and Lung meridian respectively to explore the specificity for the site-to-site association.

Interventions

Functional near infrared spectroscopy will be adopted to assess the metabolic characteristics of the Heart and Lung meridians. The probes will be left at 4 measurement sites, which include Shenmen (HT7) and Shaohai (HT3) of the Heart meridian, Taiyuan (LU9) and Chize (LU5) of the Lung meridian.

PROCEDUREMoxibustion

Two sessions of moxibustion will be performed in the Heart meridian and Lung meridian successively. Intervention in the Heart meridian: moxibustion will be performed above Shaohai (HT3) for 15 minutes. During moxibustion, the probes of near infrared spectroscopy will detect the metabolic characteristics of three measuring sites, which include the midpoint of the Heart meridian along the forearm, Chize (LU5) of the Lung meridian, and the midpoint of the Lung meridian along the forearm. Intervention in the Lung meridian: moxibustion will be performed above Chize (LU5) for 15 minutes. During moxibustion, the probes of near infrared spectroscopy will detect the metabolic characteristics of three measuring sites, which include the midpoint of the Lung meridian along the left forearm, Shaohai (HT3) of the Heart meridian, and the midpoint of the Heart meridian along the forearm.

Sponsors

The Third Affiliated hospital of Zhejiang Chinese Medical University
CollaboratorOTHER
Zhejiang Chinese Medical University
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

Inclusion criteria for COPD 1. Patients should meet the above diagnostic criteria, and the severity of COPD is in the stage of GOLD 2 or 3 based on pulmonary function testing; 2. COPD patients in the stable phase, who present with mild symptoms of cough, expectoration and short breath; 3. 35 ≤ age ≤75 years, male or female; 4. Patients have clear consciousness and could communicate with others normally; 5. Patients could understand the full study protocol and written informed consent is signed by themselves or their lineal kin. Inclusion criteria for health volunteers 1. Healthy volunteers who could provide a recent medical examination report to confirm they have not any cardiovascular, respiratory, digestive, urinary, hematological, endocrine and neurological disease; 2. Age≥20 years, male or female; 3. Participants have clear consciousness and could communicate with others normally; 4. Participants could understand the full study protocol and have high adherence .Written informed consent is signed by themselves or their lineal kin.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline regional oxygen saturation (rSO2)5-minute baseline, 15 minutes during moxibustion and 5 minutes after removal of moxibustionRegional oxygen saturation could reflect the metabolic characteristics of meridians.

Countries

China

Contacts

Primary ContactYongliang Jiang, Ph.D
jyl2182@126.com86-13858173136
Backup ContactHantong Hu
413351308@qq.com86-18667103032

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026